ECSP23089582A - Compuestos de espiroindolinona como bloqueadores del canal agitador de potasio kv1.3 - Google Patents

Compuestos de espiroindolinona como bloqueadores del canal agitador de potasio kv1.3

Info

Publication number
ECSP23089582A
ECSP23089582A ECSENADI202389582A ECDI202389582A ECSP23089582A EC SP23089582 A ECSP23089582 A EC SP23089582A EC SENADI202389582 A ECSENADI202389582 A EC SENADI202389582A EC DI202389582 A ECDI202389582 A EC DI202389582A EC SP23089582 A ECSP23089582 A EC SP23089582A
Authority
EC
Ecuador
Prior art keywords
potassium
channel blockers
agitator channel
spiroindolinone
compounds
Prior art date
Application number
ECSENADI202389582A
Other languages
English (en)
Inventor
Roger John Snow
Vishwanath Jogini
Morten Jensen
Fabrizio Giordanetto
Original Assignee
De Shaw Res Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by De Shaw Res Llc filed Critical De Shaw Res Llc
Publication of ECSP23089582A publication Critical patent/ECSP23089582A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describe un compuesto de la Fórmula I ( ) o una sal farmacéuticamente aceptable de este en donde los sustituyentes son como se definen en la presente descripción. También se describen composiciones farmacéuticas que comprenden el mismo y el método de uso del mismo.
ECSENADI202389582A 2021-05-28 2023-11-27 Compuestos de espiroindolinona como bloqueadores del canal agitador de potasio kv1.3 ECSP23089582A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202163194599P 2021-05-28 2021-05-28

Publications (1)

Publication Number Publication Date
ECSP23089582A true ECSP23089582A (es) 2023-12-29

Family

ID=84230386

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202389582A ECSP23089582A (es) 2021-05-28 2023-11-27 Compuestos de espiroindolinona como bloqueadores del canal agitador de potasio kv1.3

Country Status (14)

Country Link
EP (1) EP4351569A2 (es)
KR (1) KR20240001192A (es)
CN (1) CN117597120A (es)
AR (1) AR125994A1 (es)
AU (1) AU2022281402A1 (es)
BR (1) BR112023023951A2 (es)
CA (1) CA3219345A1 (es)
CO (1) CO2023016088A2 (es)
CR (1) CR20230555A (es)
DO (1) DOP2023000257A (es)
EC (1) ECSP23089582A (es)
IL (1) IL308277A (es)
TW (1) TW202310831A (es)
WO (1) WO2022251561A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11976067B2 (en) 2022-01-18 2024-05-07 Maze Therapeutics, Inc. APOL1 inhibitors and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4345081A (en) * 1980-02-15 1982-08-17 American Hoechst Corporation Spiro[indoline-3,4'-piperidine]s
EP2108641A1 (en) * 2008-04-11 2009-10-14 Laboratorios Almirall, S.A. New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors

Also Published As

Publication number Publication date
CO2023016088A2 (es) 2024-02-26
TW202310831A (zh) 2023-03-16
CN117597120A (zh) 2024-02-23
CR20230555A (es) 2024-02-19
WO2022251561A2 (en) 2022-12-01
BR112023023951A2 (pt) 2024-01-30
EP4351569A2 (en) 2024-04-17
DOP2023000257A (es) 2023-12-29
AR125994A1 (es) 2023-08-30
WO2022251561A3 (en) 2023-01-05
IL308277A (en) 2024-01-01
AU2022281402A1 (en) 2023-11-02
CA3219345A1 (en) 2022-12-01
KR20240001192A (ko) 2024-01-03

Similar Documents

Publication Publication Date Title
ECSP20044709A (es) Inhibidores de sarcómero cardíaco
CO2021015698A2 (es) Moduladores de thr-β y métodos de uso de estos
ECSP23089582A (es) Compuestos de espiroindolinona como bloqueadores del canal agitador de potasio kv1.3
CL2021000481A1 (es) Inhibidores de sarcómeros cardíacos.
CR20230115A (es) Compuestos heterocíclicos
CL2023002616A1 (es) Inhibidores del sarcómero cardíaco
CO2022003062A2 (es) Compuestos heterocíclicos
CO2022004305A2 (es) Compuestos heterocíclicos de arilmetileno como bloqueadores del canal shaker de potasio kv1.3
CO2023000056A2 (es) Derivados de amidopirimidona
CL2022002661A1 (es) Derivados de benzodiazepinas como pam de gaba a gamma1
CL2022000893A1 (es) Derivados de 2-azaspiro[3,4]octano como agonistas de m4
CO5601010A2 (es) Derivados de oxazolidinona, procesos para su preparacion y composiciones farmaceuticas que los contienen
CO2023015732A2 (es) Moduladores de trex1
PE20220134A1 (es) Compuestos de pirrolidina
CL2021000729A1 (es) Derivados de indano para el uso en el tratamiento de infección bacteriana
CL2023001440A1 (es) Nuevos derivados de indazol acetileno
DOP2023000209A (es) Compuestos heterocíclicos de arilo como bloqueadores del canal agitador de potasio kv1.3
UY38567A (es) Inhibidores de o-glucoproteína-2-acetamido-2-desoxi-3-d-glucopiranosidasa de éter bicíclico
AR116428A1 (es) Compuestos de 6-fluoro-2-metilbenzo[d]tiazol-5-ilo
AR127559A1 (es) Compuestos, composiciones y métodos
ECSP23075535A (es) Compuestos cíclicos y métodos de uso
CO2022006942A2 (es) Compuestos de 1,8-naftiridin-2-ona para el tratamiento de una enfermedad autoinmunitaria
AR124720A1 (es) Derivados de pirazolamida
AR124698A1 (es) Derivados tricíclicos útiles como inhibidores de parp7
AR127496A1 (es) Compuestos de cd73